Release kinetics of anti-Inflammatory drug, and characterization and bioactivity of SiO2+PCL hybrid material synthesized by sol-Gel processing

Journal of Applied Biomaterials and Functional Materials

Volumn 12, Issue 3, 2014, Pages 218-227

  Catauro, Michelina ^a   Bollino, Flavia ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Bioactivity; Drug delivery; Organic inorganic hybrid materials; Release kinetics; Sol gel process

Indexed keywords

ATOMIC FORCE MICROSCOPY; CONTROLLED DRUG DELIVERY; DRUG DOSAGE; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDROXYAPATITE; KINETICS; MEDICAL APPLICATIONS; ORGANIC-INORGANIC MATERIALS; SCANNING ELECTRON MICROSCOPY; SILICA; SOL-GEL PROCESS; TARGETED DRUG DELIVERY; ULTRAVIOLET VISIBLE SPECTROSCOPY; X RAY DIFFRACTION ANALYSIS;

ANTI-INFLAMMATORY DRUGS; DRUG RELEASE; DRUG-DELIVERY SYSTEMS; HYBRIDS MATERIAL; LOCAL DRUG DELIVERY; ORGANIC-INORGANIC HYBRID MATERIALS; RELEASE KINETICS; SIMULATED BODY FLUIDS; SOL-GEL PROCESSING; SYNTHESISED;

BIOACTIVITY;

CARBONYL DERIVATIVE; HYDROXYAPATITE; KETOPROFEN; POLYCAPROLACTONE; POLYMER; SILICON DIOXIDE; DELAYED RELEASE FORMULATION; NONSTEROID ANTIINFLAMMATORY AGENT; POLYESTER;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOLOGICAL ACTIVITY; BODY FLUID; CHEMICAL PROCEDURES; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYDROGEN BOND; IN VITRO STUDY; SCANNING ELECTRON MICROSCOPY; SOL GEL PROCESS; SYNTHESIS; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION; ADMINISTRATION AND DOSAGE; CHEMISTRY; CRYSTALLIZATION; DELAYED RELEASE FORMULATION; DIFFUSION; KINETICS; MATERIALS TESTING; PHASE TRANSITION; PROCEDURES;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY FLUIDS; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; DIFFUSION; KETOPROFEN; KINETICS; MATERIALS TESTING; PHASE TRANSITION; POLYESTERS; SILICON DIOXIDE;

EID: 84926688854     PISSN: None     EISSN: 22808000     Source Type: Journal    
DOI: 10.5301/JABFM.5000160     Document Type: Article

References (56)

1. Vallet-Regí M. Ceramics for medical applications. J Chem Soc Dalton. 2001; 2: 97-108.
2. Vallet-Regí M, Arcos D. Nanostructured hybrid materials for bone tissue regeneration. Current Nanoscience. 2006; 2(3): 179-189.
3. Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chemistry - A European Journal. 2006; 12: 5934-5943.
4. Vallet-Regí M. Bone repair and regeneration: possibilities. Materialwiss Werkst. 2006; 37(6): 478-484.
5. Black J, Hastings G, eds. Handbook of biomaterial properties. New York: Chapman & Hall; 1998.
6. Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater. 2000; 13(2): 308-311.
7. Ragel CV, Vallet-Regí M. In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. J Biomed Mater Res. 2000; 51(3): 424-429.
8. Arcos D, Ragel CV, Vallet-Regí M. Bioactivity in glass/ PMMA composites used as drug delivery system. Biomaterials. 2001; 22(7): 701-708.
9. Judeinstein P, Sanchez C. Hybrid organic-inorganic materials: a land of multidisciplinarity. J Mater Chem. 1996; 6(4): 511-525.
10. Hench LL, West JK. The sol-gel process. Chem Rev. 1990; 90(1): 33-72.
11. Novak BM. Hybrid nanocomposite materials: between inorganic glasses and organic polymers. Adv Mater. 1993; 5(6): 422-433.
12. Hsiue GH, Kuo JK, Jeng RJ, et al. Stable second-order nonlinear optical polymer network based on an organosoluble polyimide. Chem Mater. 1994; 6(7): 884-887.
13. Wei Y, Xu J, Dong H, Dong JH, Qiu K, Jansen-Varnum SA. Preparation and physisorption characterization of d-glucose- templated mesoporous silica sol-gel materials. Chem Mater. 1999; 11(8): 2023-2029.
14. Klein CPAT, eds. Sol-gel technology for thin films, fibers, preforms, electronics and specialty shapes. Park Ridge, NJ: Noyes; 1988.
15. Brinker CJ, Scherer GW, eds. Sol-gel science, the physics and chemistry of sol-gel processing. San Diego, CA: Academic Press; 1989.
16. Wei Y, Bakthavatchalam R, Whitecar CK. Synthesis of new organic-inorganic hybrid glasses. Chem Mater. 1990; 2(4): 337-339.
17. 2 hybrid sol-gel materials. Mater Lett. 1992; 13(4-5): 261-266.
18. Hay JN, Raval HM. Synthesis of organic-inorganic hybrids via the non-hydrolytic sol-gel process. Chem Mater. 2001; 13(10): 3396-3403.
19. Gao Y, Choudhury NR, Dutta N, Matisons J, Reading M, Delmotte L. Organic-inorganic hybrid from ionomer via sol-gel reaction. Chem Mater. 2001; 13(10): 3644-3652.
20. David IA, Scherer GW. An organic/inorganic single-phase composite. Chem Mater. 1995; 7(10): 1957-1967.
21. Fitzgerald JJ, Landry CJT, Pochan JM. Dynamic studies of the molecular relaxations and interactions in microcomposites prepared by in situ polymerization of silicon alkoxides. Macromolecules. 1992; 25(14): 3715-3722.
22. Saegusa T. Organic/inorganic polymer hybrids. Macromol Symp. 1995; 98(1): 719-729.
23. Klein LL, Sanchez C. Hybrid organic-inorganic materials. J Sol-Gel Sci Technol. 1995; 5: 75-157.
24. Sanchez C, Ribot F. Design of hybrid organic-inorganic materials synthesized via sol-gel chemistry. New J Chem. 1994; 18: 1007-47.
25. Young SK, Gemeinhardt GC, Sherman JW, et al. Covalent and non-covalently coupled polyester-inorganic composite materials. Polymer (Guildf). 2002; 43(23): 6101-6114.
26. Hench LL, Splinter RJ, Allen WC, Greenlee TK. Bonding mechanisms at the interface of ceramic prosthetic materials. Biomed Mater Symp. 1971; 2: 117-141.
27. Kokubo T. Bioactive glass ceramics: properties and applications. Biomaterials. 1991; 12(2): 155-163.
28. 5 glasses in a simulated body fluid. J Non-Cryst Solids. 1992; 143: 84-92.
29. Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res. 2001; 55(2): 203-216.
30. Khor HL, Ng KW, Schantz JT, et al. Poly(3-caprolactone) films as a potential substrate for tissue engineering: an epidermal equivalent. Mater Sci Eng C. 2002; 20(1-2): 71-75.
31. Allen C, Han J, Yu Y, Maysinger D, Eisenberg A. Polycaprolactone- b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J Control Release. 2000; 63(3): 275-286.
32. Chen B, Evans JR. Poly(3-caprolactone)-clay nanocomposites: structure and mechanical properties. Macromolecules. 2005; 39(2): 747-754.
33. Messersmith PB, Giannelis EP. Polymer-layered silicate nanocomposites: in situ intercalative polymerization of n-caprolactone in layered silicates. Chem Mater. 1993; 5(8): 1064-1066.
34. Nie K, Pang W, Wang Y, Lu F, Zhu Q. Effects of specific bonding interactions in poly(b-caprolactone)/silica hybrid materials on optical transparency and melting behavior. Mater Lett. 2005; 59(11): 1325-1328.
35. Wu C-S. In situ polymerization of titanium isopropoxide in polycaprolactone: properties and characterization of the hybrid nanocomposites. J Appl Polym Sci. 2004; 92(3): 1749-1757.
36. Catauro M, Bollino F. Anti-inflammatory entrapment in polycaprolactone/ silica hybrid material prepared by sol-gel route, characterization, bioactivity and in vitro release behavior. J Appl Biomater Funct Mater. 2013;11(3):172-179.
37. Catauro M, Melisi D, Curcio A, Rimoli MG. Sol-gel processing of anti-inflammatory entrapment in silica, release kinetics, and bioactivity. J Biomed Mater Res. 2008; 87A(4): 843-849.
38. 2 hybrid material. J Mater Sci Mater Med. 2004; 15(9): 991-995.
39. 2 hybrid material. J Mater Sci. 2003; 38(14): 3097-3102.
40. De Gaetano F, Ambrosio L, Raucci MG, Marotta A, Catauro M. Sol-gel processing of drug delivery materials and release kinetics. J Mater Sci Mater Med. 2005; 16(3): 261-265.
41. 2/PCL hybrid materials synthesized by sol-gel processing. J Biomed Mater Res A. 2006; 77A(2): 340-350.
42. 2 synthesized by sol-gel processing. J Mater Sci Mater Med. 2006; 17(5): 413-420.
43. Catauro M, Raucci M, Ausanio G. Sol-gel processing of drug delivery zirconia/polycaprolactone hybrid materials. J Mater Sci Mater Med. 2008; 19(2): 531-540.
44. Catauro M, Verardi D, Melisi D, Belotti F, Mustarelli P. Novel sol-gel organic-inorganic hybrid materials for drug delivery. J Appl Biomat Biomech. 2010; 8: 42-51.
45. Catauro M, Raucci MG, Continenza MA. Release kinetics of ampicillin, biocompatibility tests with a fibroblast strain of a zirconia gel glass. Lett Drug Des Discov. 2007; 4: 453-459.
46. Teoli D, Parisi L, Realdon N, Guglielmi M, Rosato A, Morpurgo M. Wet sol-gel derived silica for controlled release of proteins. J Control Release. 2006; 116(3): 295-303.
47. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006; 27(15): 2907-2915.
48. Hench LL, Clark DE. Physical chemistry of glass surfaces. J Non-Cryst Solids. 1978; 28(1): 83-105.
49. Paul A, eds. Chemistry of glasses. New York: Chapman and Hall; 1990: 184.
50. Thomas M. The Lambert-Beer law. In: Ando DJ, eds. Ultraviolet and visible spectroscopy. New York, USA: Wiley; 1996: 16-30.
51. Sanchez C, Livage J, Henry M, Babonneau F. Chemical modification of alkoxide precursors. J Non-Cryst Solids. 1988; 100(1-3): 65-76.
52. Wang DS, Pantano CG. Surface chemistry of multicomponent silicate gels. J Non-Cryst Solids. 1992; 147-148: 115-122.
53. Kim CY, Clark AE, Hench LL. Early stages of calcium-phosphate layer formation in bioglasses. J Non-Cryst Solids. 1989; 113(2-3): 195-202.
54. Rädlein E, Frischat GH. Atomic force microscopy as a tool to correlate nanostructure to properties of glasses. J Non- Cryst Solids. 1997; 222: 69-82.
55. Wei Y, Jin D, Brennan DJ, et al. Atomic force microscopy study of organic-inorganic hybrid materials. Chem Mater. 1998; 10(3): 769-772.
56. Hench LL. Bioceramics: from concept to clinic. J Am Ceram Soc. 1991; 74(7): 1487-1510.